NEW YORK (GenomeWeb) – OpGen announced today that it has received notification from the Nasdaq that it has regained compliance with the market's applicable listing standards, and that its stock will continue to be listed and traded on the exchange.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.
NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.
A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.
In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.